loadpatents
Patent applications and USPTO patent grants for Gui; Xun.The latest application filed is for "novel lilrb4 antibodies and uses thereof".
Patent | Date |
---|---|
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer Grant 11,377,491 - Liao , et al. July 5, 2 | 2022-07-05 |
Novel Lilrb4 Antibodies And Uses Thereof App 20210371518 - AN; Zhiqiang ;   et al. | 2021-12-02 |
Methods For Identifying Lilrb-blocking Antibodies App 20210349096 - ZHANG; Chengcheng ;   et al. | 2021-11-11 |
Targeting Lilrb4 With Car-t Or Car-nk Cells In The Treatment Of Cancer App 20210179687 - ZHANG; Chengcheng ;   et al. | 2021-06-17 |
Anti-lilrb Antibodies And Their Use In Detecting And Treating Cancer App 20200079851 - ZHANG; Chengcheng ;   et al. | 2020-03-12 |
Anti-LILRB antibodies and their use in detecting and treating cancer Grant 10,501,538 - Zhang , et al. Dec | 2019-12-10 |
Anti-lair1 Antibodies And Their Uses App 20190338026 - LIAO; X. Charlene ;   et al. | 2019-11-07 |
Anti-lilrb Antibodies And Their Use In Detecting And Treating Cancer App 20180086829 - ZHANG; Chengcheng ;   et al. | 2018-03-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.